January 2022 - Page 4 of 27

ThursdayJan 27, 2022 12:30 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is…

ThursdayJan 27, 2022 11:47 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Key Milestone in Commercialization of Ultra Shear Technology(TM)

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and beverage, biotherapeutics and personal wellness industries, among others, today announced the commissioning of its first production-scale, patented Ultra Shear Technology(TM) (“UST(TM)”) platform. Per the update, the BaroShear MAX UST processing system was installed and commissioned in The Ohio State University College of Food, Agricultural and Environmental Sciences (“CFAES”). Together with the previously announced formation of the Food Industry Consortium, co-led by PBI and Ohio State, this completes one of the last remaining critical…

ThursdayJan 27, 2022 11:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://ibn.fm/w6zLQ) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing SARS-CoV-2, whereas oral delivery methods are effective Lexaria has been studying and researching the oral delivery of compounds using its patented DehydraTECH(TM) technology, which enhances bioavailability and absorption, requiring less heat than smoking or vaping and leaving the cannabinoid compounds undamaged Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, commented on an independent January 10 study headed…

ThursdayJan 27, 2022 11:22 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Scheduled Release of Q3 Financial Results, Conference Call

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will report financial results for its third quarter ended Dec. 31, 2021, on Thursday, Feb. 10, 2022. According to the announcement, a conference call will be held on the same day at 8:30 a.m. ET to discuss the results and recent business updates. Cybin’s Chief Executive Officer Doug Drysdale will host the call and, following prepared remarks, Drysdale and other members of the management team will be available to answer questions from participants. Interested parties should visit https://ibn.fm/quTwC to register for…

ThursdayJan 27, 2022 11:07 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp.…

ThursdayJan 27, 2022 11:00 am

SPYR Inc. (SPYR) Subsidiary, Applied Magix, Announces Marketing Campaign with Dynamic TV Ads for MagixDrive Product

Applied Magix’s product selection for consumers includes The MagixDrive Wireless CarPlay Adapter, The HomeKit Secure Video Camera with iCloud Storage, The Multipurpose Sensor with Alarm, The Environment and Motion Sensor, and The Window and Door Contact Sensor The next phase of the ad campaign will ramp up the frequency of the ads and expand upon a higher interest profile of viewers Smart home market size was valued at $98.24 billion in 2020 and is expected to grow at a CAGR of 23.59% from 2021 to 2028 Technology company SPYR (OTCQB: SPYR), dba SPYR Technologies, announced the expansion of a comprehensive…

ThursdayJan 27, 2022 10:30 am

Sugarmade Inc.’s (SGMD) Progress in 2021 Leads to Strong Position in Growing Cannabis Space

A legal cannabis market size projected to grow at CAGR of 16.6% from 2022 to 2028 More than 3,500 peer-reviewed scientific papers studying cannabis were published in 2020 alone SGMD reaches key objectives, seeing key growth in 2021 After a year of impressive progress and growth, Sugarmade (OTC: SGMD) has established an enviable position in the legal cannabis market, a sector that is expected to see an estimated 16.6% growth in the coming years (https://ibn.fm/ELp2X). “The North America legal cannabis market size was valued at USD 12.4 billion in 2021 and is projected to grow at a compound annual growth rate…

ThursdayJan 27, 2022 10:27 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet's patients using RYAH Smart Inhalers and data analytics, once certified as a medical device in Israel, with the goal of providing safe and accurate patient inhalation therapies in plant medicine. “Bazelet brings extraordinary depth and expertise within a well-established and fast-growing medical cannabis market. We're excited to be collaborating with Bazelet in bringing our smart…

ThursdayJan 27, 2022 10:00 am

LiDAR Detects Merger Between Cepton and Growth Capital Acquisition Corp. (NASDAQ: GCAC) Drawing Near

Six LiDAR companies have gone public since 2020, raising $3.6+ billion as investors look for exposure to autonomous vehicles market Cepton is merging with Growth Capital Acquisition Corp GCAC in the coming weeks in a deal valuing Cepton at $1.55 billion, with $231 million in pro forma cash on its balance sheet Cepton has worked with the world’s biggest automotive OEMs, including General Motors and Ford, and garnered a $50 million investment for Japan’s Koito Manufacturing As the race to fully autonomous vehicles (“AVs”) heats up, one particularly important pocket of the AV and advanced driver assistance systems (“ADAS”) markets…

ThursdayJan 27, 2022 9:30 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Vision Strengthens Company’s Position in Emerging Wellness Trend

Psychedelics pose potential as effective treatments for mental-health issues such as depression, anxiety, and substance abuse Well+Good says psychedelics “poised to change the course of mental health treatment” Cybin working to combine novel psychedelic molecules with controllable drug-delivery systems through proprietary deuterated process A USA Today article is touting psychedelics as the next big thing in mental health treatment (https://ibn.fm/3ZGGE). This forecast aligns perfectly with what Cybin (NEO: CYBN) (NYSE American: CYBN) has been working toward since the company started: a strategic psychedelics to therapeutics model that will transform the mental health space. “If you haven't heard about psychedelics being used as a treatment…

Site Search

Company Search

Month: January 2022